Endo Health Solutions News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.12.13	Endo Health Solutions Inc. -- Moody's assigns Ba1 to Endo's new senior secured bank facilities (Moodys)
06.11.13	MYGN, SGEN Boost Outlook, AMRI On A High, ENDP Opens Wallet, IMGN Slammed (RTTNews)
05.11.13	Endo Health Solutions Inc. -- Moody's affirms Endo at Ba3; negative outlook (Moodys)
05.11.13	Pre-market Movers For Nov 5 (AOL, CVS, ENDP, KORS, CYTX, GTAT, IMGN, BSFT, OTEX) (RTTNews)
05.11.13	Endo Health To Buy Paladin Labs, Post Lower Q3 Profit (RTTNews)
15.10.13	Under AAAResearchReports.com Microscope: Eli Lilly & Co., Bristol-Myers Squibb Co., Allergan Inc., and Endo Health Solutions Inc. (PR Newswire)
17.09.13	Pre-Market Review: Bristol-Myers Squibb Co., Eli Lilly & Co., Endo Health Solutions Inc., and Allergan Inc. (PR Newswire)
17.09.13	Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest (PR Newswire)
11.09.13	Acquisitions, Regulatory Filings, New Community Resource Centers and Successful Clinical Trials- Research Report on Baxter, Endo, HCA, Elan, and Theravance (PR Newswire)
09.09.13	Endo Health Solutions Names Suketu Upadhyay CFO - Quick Facts (RTTNews)
06.09.13	Endo Health Solutions to Present at the Stifel Nicolaus 2013 Healthcare Conference (PR Newswire)
05.09.13	FDA Accepts Endo's Complete Response Submission To NDA For Aveed Injection (RTTNews)
05.09.13	FDA Accepts Endo's Complete Response Submission to New Drug Application for AVEED™ (Testosterone Undecanoate) Injection (PR Newswire)
04.09.13	Endo And BioDelivery Sciences Update On BEMA Buprenorphine Phase III Trials (RTTNews)
04.09.13	Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program (PR Newswire)
02.09.13	Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip (PR Newswire)
29.08.13	AEZS Shifts Listing, AUXL Gets New Decision Date, Teva Hangs Up On RNN Deal (RTTNews)
28.08.13	Endo Health To Buy Privately Held Generics Firm Boca Pharmacal For $225 Mln Cash (RTTNews)
14.08.13	Critical Alerts For Facebook, Orbitz, Eli Lilly, Dominion Resources, and Endo Pharmaceuticals Released By InvestorsObserver (PR Newswire)
12.08.13	Endo and Metamark Announce Sale of HealthTronics Laboratory Solutions (PR Newswire)
12.08.13	Early Briefing and Review: Bristol-Myers Squibb Co., Eli Lilly & Co., Allergan Inc., and Endo Health Solutions Inc. (PR Newswire)
12.08.13	Financial Results Release, Management Changes, and Newly Issued Permits - Research Report on Valeant, Teva, Endo, Array, and Sequenom (PR Newswire)
06.08.13	Endo Health Solutions Q2 Profit Rises - Quick Facts (RTTNews)
06.08.13	Endo Reports Second Quarter Financial Results (PR Newswire)
29.07.13	Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013 (PR Newswire)
25.07.13	Settlements, Significant Study Results, and Product Launches Lead to Advancements in Patient Care - Research Report on GSK, Isis, Endo, Pacira, and Dr. Reddy's (PR Newswire)
22.07.13	American Medical Systems Launches MiniArc™ Pro Single-Incision Sling System for Treatment of Female Stress Urinary Incontinence (PR Newswire)
22.07.13	Endo Health Solutions Appoints Don DeGolyer As COO, Pharmaceuticals (RTTNews)
24.02.12	Endo Pharmaceuticals meldet Ergebnis für viertes Quartal (Aktiencheck)
12.12.11	Endo Pharmaceuticals erhält FDA-Zulassung für neue Version des Schmerzmittels Opana (Aktiencheck)
15.05.09	Tang Capital Partners, LP and Perceptive Life Sciences Master Fund Ltd. Urge the Shareholders of Penwest Pharmaceuticals Co. to Vote for Their Shareholder Proposals (Businesswire)
03.03.09	Tang Capital Partners, LP and Perceptive Life Sciences Master Fund Ltd. Urge the Board of Directors of Penwest Pharmaceuticals Co. to Take Immediate Action to Preserve Shareholder Value (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Endo Health Solutions Inc.

Aktien Top/Flop

Meistgelesene Nachrichten